 Joanna Arch
Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acceptance and Commitment Therapy | 18 | 2026 | 31 | 9.300 |
Why?
| | Cancer Survivors | 15 | 2024 | 330 | 6.780 |
Why?
| | Anxiety Disorders | 28 | 2025 | 370 | 6.030 |
Why?
| | Anxiety | 30 | 2026 | 1122 | 5.460 |
Why?
| | Neoplasms | 19 | 2026 | 2873 | 3.820 |
Why?
| | Implosive Therapy | 10 | 2025 | 48 | 3.790 |
Why?
| | Phobia, Social | 5 | 2023 | 13 | 2.620 |
Why?
| | Advance Care Planning | 4 | 2026 | 243 | 2.360 |
Why?
| | Fear | 8 | 2025 | 366 | 1.970 |
Why?
| | Adaptation, Psychological | 9 | 2025 | 718 | 1.880 |
Why?
| | Mindfulness | 4 | 2020 | 154 | 1.340 |
Why?
| | Stress, Psychological | 7 | 2020 | 1148 | 1.290 |
Why?
| | Ovarian Neoplasms | 3 | 2026 | 589 | 1.230 |
Why?
| | Breast Neoplasms | 4 | 2023 | 2365 | 1.220 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 3 | 2026 | 132 | 1.140 |
Why?
| | Fatigue | 3 | 2026 | 363 | 1.100 |
Why?
| | Self Concept | 3 | 2023 | 256 | 1.090 |
Why?
| | Adult | 52 | 2026 | 40489 | 1.090 |
Why?
| | Depression | 8 | 2026 | 1561 | 1.050 |
Why?
| | Medication Adherence | 4 | 2025 | 540 | 1.050 |
Why?
| | Quality of Life | 15 | 2026 | 3183 | 1.010 |
Why?
| | Meditation | 3 | 2016 | 37 | 0.940 |
Why?
| | Humans | 82 | 2026 | 144667 | 0.930 |
Why?
| | Writing | 1 | 2025 | 102 | 0.800 |
Why?
| | Social Learning | 1 | 2023 | 5 | 0.800 |
Why?
| | Female | 55 | 2026 | 78304 | 0.790 |
Why?
| | Health Behavior | 4 | 2025 | 786 | 0.780 |
Why?
| | Affect | 1 | 2025 | 322 | 0.710 |
Why?
| | Survivors | 4 | 2023 | 519 | 0.670 |
Why?
| | Empathy | 3 | 2018 | 184 | 0.650 |
Why?
| | Hospice and Palliative Care Nursing | 1 | 2022 | 115 | 0.650 |
Why?
| | Anti-Anxiety Agents | 2 | 2013 | 47 | 0.640 |
Why?
| | Safety | 2 | 2019 | 356 | 0.620 |
Why?
| | Surveys and Questionnaires | 15 | 2024 | 6041 | 0.610 |
Why?
| | Motivational Interviewing | 1 | 2021 | 122 | 0.600 |
Why?
| | Terminal Care | 1 | 2023 | 283 | 0.600 |
Why?
| | Middle Aged | 25 | 2026 | 35971 | 0.590 |
Why?
| | Disease Susceptibility | 1 | 2021 | 342 | 0.590 |
Why?
| | Psycho-Oncology | 1 | 2019 | 4 | 0.590 |
Why?
| | Male | 43 | 2026 | 72431 | 0.570 |
Why?
| | Avoidance Learning | 1 | 2019 | 63 | 0.560 |
Why?
| | Young Adult | 19 | 2024 | 14122 | 0.560 |
Why?
| | Randomized Controlled Trials as Topic | 6 | 2026 | 1742 | 0.540 |
Why?
| | Aged | 15 | 2026 | 25955 | 0.540 |
Why?
| | Salivary alpha-Amylases | 2 | 2016 | 4 | 0.530 |
Why?
| | Telemedicine | 2 | 2026 | 957 | 0.530 |
Why?
| | Self-Help Groups | 1 | 2017 | 36 | 0.520 |
Why?
| | Obsessive-Compulsive Disorder | 2 | 2015 | 59 | 0.510 |
Why?
| | Feedback, Psychological | 1 | 2017 | 24 | 0.510 |
Why?
| | Attention | 5 | 2016 | 458 | 0.510 |
Why?
| | Chemotherapy, Adjuvant | 3 | 2023 | 427 | 0.510 |
Why?
| | Feasibility Studies | 6 | 2024 | 1103 | 0.500 |
Why?
| | Patient Acceptance of Health Care | 3 | 2021 | 881 | 0.500 |
Why?
| | Behavior Therapy | 3 | 2019 | 300 | 0.500 |
Why?
| | Pregnancy Complications | 2 | 2012 | 586 | 0.490 |
Why?
| | Heart Rate | 4 | 2014 | 853 | 0.490 |
Why?
| | Prejudice | 1 | 2017 | 61 | 0.490 |
Why?
| | Crowdsourcing | 1 | 2016 | 18 | 0.480 |
Why?
| | Disease Progression | 1 | 2024 | 2847 | 0.470 |
Why?
| | Diabetes Mellitus | 1 | 2025 | 1076 | 0.470 |
Why?
| | Patient Preference | 2 | 2017 | 226 | 0.460 |
Why?
| | Awareness | 3 | 2013 | 109 | 0.460 |
Why?
| | Pilot Projects | 5 | 2024 | 1886 | 0.450 |
Why?
| | Auditory Perceptual Disorders | 1 | 2015 | 8 | 0.450 |
Why?
| | Stress Disorders, Traumatic | 1 | 2015 | 25 | 0.440 |
Why?
| | Treatment Outcome | 19 | 2024 | 11735 | 0.440 |
Why?
| | Hyperventilation | 3 | 2014 | 15 | 0.430 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2021 | 1406 | 0.430 |
Why?
| | Emotions | 4 | 2017 | 578 | 0.410 |
Why?
| | Social Support | 2 | 2017 | 650 | 0.400 |
Why?
| | Psychotherapy | 2 | 2012 | 190 | 0.390 |
Why?
| | Data Collection | 1 | 2016 | 635 | 0.390 |
Why?
| | Women | 1 | 2013 | 50 | 0.390 |
Why?
| | Mind-Body Therapies | 1 | 2013 | 9 | 0.380 |
Why?
| | Interinstitutional Relations | 1 | 2013 | 53 | 0.380 |
Why?
| | Learning | 1 | 2017 | 448 | 0.370 |
Why?
| | Pituitary-Adrenal System | 1 | 2014 | 163 | 0.370 |
Why?
| | Alcohol Drinking | 2 | 2012 | 827 | 0.360 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2014 | 196 | 0.360 |
Why?
| | Relaxation | 2 | 2014 | 3 | 0.340 |
Why?
| | Speech | 3 | 2023 | 78 | 0.330 |
Why?
| | Feeding Behavior | 2 | 2016 | 686 | 0.330 |
Why?
| | Attitude to Health | 1 | 2013 | 431 | 0.320 |
Why?
| | Biomedical Research | 2 | 2016 | 712 | 0.310 |
Why?
| | Psychiatry | 1 | 2013 | 196 | 0.310 |
Why?
| | Academic Medical Centers | 1 | 2013 | 545 | 0.300 |
Why?
| | Severity of Illness Index | 8 | 2021 | 2922 | 0.290 |
Why?
| | Motivation | 2 | 2025 | 601 | 0.280 |
Why?
| | United States Department of Veterans Affairs | 1 | 2013 | 771 | 0.270 |
Why?
| | Self-Assessment | 2 | 2023 | 75 | 0.260 |
Why?
| | Palliative Care | 3 | 2026 | 1011 | 0.250 |
Why?
| | Panic Disorder | 1 | 2007 | 22 | 0.250 |
Why?
| | Pregnancy | 4 | 2020 | 7122 | 0.240 |
Why?
| | Community Mental Health Services | 2 | 2018 | 86 | 0.240 |
Why?
| | Respiration | 1 | 2006 | 206 | 0.220 |
Why?
| | Alcohol-Related Disorders | 1 | 2006 | 120 | 0.210 |
Why?
| | Uncertainty | 1 | 2024 | 145 | 0.200 |
Why?
| | Longitudinal Studies | 4 | 2022 | 2942 | 0.200 |
Why?
| | Adolescent | 10 | 2023 | 22409 | 0.200 |
Why?
| | Pandemics | 2 | 2023 | 1700 | 0.200 |
Why?
| | Psychotherapy, Group | 2 | 2015 | 80 | 0.200 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2018 | 539 | 0.200 |
Why?
| | Phobic Disorders | 2 | 2014 | 35 | 0.200 |
Why?
| | Patient Dropouts | 2 | 2017 | 65 | 0.190 |
Why?
| | Saliva | 2 | 2016 | 247 | 0.190 |
Why?
| | Death | 1 | 2023 | 131 | 0.190 |
Why?
| | United States | 5 | 2024 | 16018 | 0.180 |
Why?
| | Models, Psychological | 2 | 2017 | 297 | 0.180 |
Why?
| | Prospective Studies | 3 | 2026 | 7994 | 0.170 |
Why?
| | Cognition | 3 | 2023 | 1263 | 0.170 |
Why?
| | Relaxation Therapy | 2 | 2012 | 19 | 0.170 |
Why?
| | Catastrophization | 1 | 2021 | 16 | 0.170 |
Why?
| | Aged, 80 and over | 3 | 2025 | 8284 | 0.170 |
Why?
| | Reward | 1 | 2023 | 245 | 0.170 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2022 | 192 | 0.170 |
Why?
| | Amoxicillin-Potassium Clavulanate Combination | 1 | 2000 | 16 | 0.160 |
Why?
| | Cephalosporins | 1 | 2000 | 47 | 0.160 |
Why?
| | Cholecystectomy | 1 | 2000 | 61 | 0.160 |
Why?
| | Affective Symptoms | 1 | 2020 | 53 | 0.160 |
Why?
| | Patient Reported Outcome Measures | 1 | 2024 | 496 | 0.160 |
Why?
| | Ecological Momentary Assessment | 1 | 2020 | 47 | 0.160 |
Why?
| | Pharmaceutical Services | 1 | 2020 | 76 | 0.150 |
Why?
| | Antibiotic Prophylaxis | 1 | 2000 | 134 | 0.150 |
Why?
| | Factor Analysis, Statistical | 1 | 2020 | 290 | 0.150 |
Why?
| | Community Health Services | 1 | 2021 | 231 | 0.150 |
Why?
| | Thinking | 1 | 2019 | 66 | 0.140 |
Why?
| | Case-Control Studies | 3 | 2017 | 3603 | 0.140 |
Why?
| | Medical Oncology | 1 | 2021 | 331 | 0.130 |
Why?
| | Clinical Competence | 2 | 2018 | 1237 | 0.130 |
Why?
| | Surgical Wound Infection | 1 | 2000 | 330 | 0.130 |
Why?
| | Stakeholder Participation | 1 | 2018 | 83 | 0.130 |
Why?
| | Adult Children | 1 | 2017 | 27 | 0.130 |
Why?
| | Comorbidity | 2 | 2020 | 1652 | 0.130 |
Why?
| | Child of Impaired Parents | 1 | 2017 | 38 | 0.130 |
Why?
| | Reference Values | 3 | 2012 | 794 | 0.120 |
Why?
| | Metaphor | 1 | 2016 | 6 | 0.120 |
Why?
| | Brain | 2 | 2023 | 2934 | 0.120 |
Why?
| | Pleasure | 1 | 2016 | 18 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2023 | 1145 | 0.120 |
Why?
| | Decision Making | 1 | 2023 | 973 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2022 | 944 | 0.110 |
Why?
| | Marketing of Health Services | 1 | 2015 | 15 | 0.110 |
Why?
| | Mental Health | 1 | 2022 | 792 | 0.110 |
Why?
| | Food | 1 | 2016 | 148 | 0.110 |
Why?
| | Social Alienation | 1 | 2014 | 2 | 0.110 |
Why?
| | Social Behavior | 1 | 2017 | 287 | 0.110 |
Why?
| | Terminology as Topic | 1 | 2016 | 255 | 0.100 |
Why?
| | Counseling | 1 | 2017 | 405 | 0.100 |
Why?
| | Forecasting | 1 | 2016 | 391 | 0.100 |
Why?
| | Energy Intake | 2 | 2016 | 501 | 0.100 |
Why?
| | Hydrocortisone | 1 | 2016 | 297 | 0.100 |
Why?
| | Feeding and Eating Disorders | 1 | 2016 | 165 | 0.100 |
Why?
| | Panic | 1 | 2012 | 8 | 0.090 |
Why?
| | Interviews as Topic | 3 | 2018 | 905 | 0.090 |
Why?
| | Research | 1 | 2016 | 431 | 0.090 |
Why?
| | Ethics Committees, Research | 1 | 2013 | 40 | 0.090 |
Why?
| | Evidence-Based Medicine | 2 | 2015 | 732 | 0.090 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2024 | 889 | 0.090 |
Why?
| | Community-Institutional Relations | 1 | 2013 | 100 | 0.090 |
Why?
| | Psychometrics | 1 | 2016 | 731 | 0.090 |
Why?
| | Follow-Up Studies | 4 | 2015 | 5414 | 0.090 |
Why?
| | Reproducibility of Results | 2 | 2016 | 3414 | 0.080 |
Why?
| | Internet | 1 | 2016 | 698 | 0.080 |
Why?
| | Observer Variation | 1 | 2012 | 355 | 0.080 |
Why?
| | Weight Loss | 1 | 2016 | 839 | 0.080 |
Why?
| | Linear Models | 1 | 2012 | 845 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2660 | 0.080 |
Why?
| | Desensitization, Psychologic | 1 | 2009 | 2 | 0.080 |
Why?
| | Risk | 1 | 2012 | 911 | 0.080 |
Why?
| | Biofeedback, Psychology | 1 | 2010 | 35 | 0.080 |
Why?
| | Self Report | 4 | 2016 | 869 | 0.080 |
Why?
| | Cooperative Behavior | 1 | 2013 | 464 | 0.080 |
Why?
| | Treatment Refusal | 1 | 2009 | 98 | 0.070 |
Why?
| | Patient Selection | 1 | 2013 | 727 | 0.070 |
Why?
| | Analysis of Variance | 2 | 2014 | 1301 | 0.070 |
Why?
| | Socioeconomic Factors | 1 | 2012 | 1322 | 0.070 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 2007 | 31 | 0.060 |
Why?
| | Patient Education as Topic | 1 | 2012 | 771 | 0.060 |
Why?
| | Breathing Exercises | 1 | 2006 | 21 | 0.060 |
Why?
| | Volition | 1 | 2006 | 34 | 0.060 |
Why?
| | Obesity | 2 | 2016 | 3070 | 0.060 |
Why?
| | Benzodiazepines | 1 | 2007 | 168 | 0.060 |
Why?
| | Patient Compliance | 1 | 2009 | 587 | 0.060 |
Why?
| | Proof of Concept Study | 1 | 2024 | 88 | 0.050 |
Why?
| | Health Services Accessibility | 3 | 2018 | 1098 | 0.050 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 1056 | 0.050 |
Why?
| | Visual Perception | 1 | 2006 | 182 | 0.050 |
Why?
| | Combined Modality Therapy | 1 | 2007 | 1268 | 0.050 |
Why?
| | Telephone | 1 | 2023 | 176 | 0.050 |
Why?
| | Qualitative Research | 2 | 2020 | 1668 | 0.050 |
Why?
| | Muscles | 1 | 2023 | 332 | 0.050 |
Why?
| | Dyspnea | 1 | 2023 | 250 | 0.040 |
Why?
| | Gallbladder Diseases | 1 | 2000 | 11 | 0.040 |
Why?
| | Biliary Tract Diseases | 1 | 2000 | 33 | 0.040 |
Why?
| | Veterans | 1 | 2013 | 1614 | 0.040 |
Why?
| | Logistic Models | 1 | 2006 | 2114 | 0.040 |
Why?
| | Mental Disorders | 1 | 2009 | 1154 | 0.040 |
Why?
| | Probability | 1 | 2000 | 309 | 0.040 |
Why?
| | Infusions, Intravenous | 1 | 2000 | 422 | 0.040 |
Why?
| | Age Factors | 1 | 2007 | 3329 | 0.040 |
Why?
| | Walking | 1 | 2023 | 542 | 0.040 |
Why?
| | Community Mental Health Centers | 1 | 2018 | 14 | 0.030 |
Why?
| | Los Angeles | 1 | 2018 | 76 | 0.030 |
Why?
| | Administration, Oral | 1 | 2000 | 851 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2014 | 2117 | 0.030 |
Why?
| | Cerebral Ventricles | 1 | 1997 | 54 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2000 | 638 | 0.030 |
Why?
| | Community-Based Participatory Research | 1 | 2018 | 166 | 0.030 |
Why?
| | Family Relations | 1 | 2017 | 88 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2000 | 1995 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2016 | 170 | 0.030 |
Why?
| | Primary Health Care | 1 | 2006 | 1730 | 0.030 |
Why?
| | Focus Groups | 1 | 2018 | 566 | 0.030 |
Why?
| | Personal Satisfaction | 1 | 2017 | 220 | 0.030 |
Why?
| | Caregivers | 1 | 2023 | 1062 | 0.030 |
Why?
| | Risk Factors | 2 | 2017 | 10796 | 0.030 |
Why?
| | Marital Status | 1 | 2014 | 46 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2015 | 198 | 0.030 |
Why?
| | Incidence | 1 | 2000 | 2892 | 0.020 |
Why?
| | Personality | 1 | 2014 | 128 | 0.020 |
Why?
| | Waiting Lists | 1 | 2014 | 263 | 0.020 |
Why?
| | Educational Status | 1 | 2014 | 463 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 2089 | 0.020 |
Why?
| | Pulmonary Ventilation | 1 | 2012 | 82 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 1016 | 0.020 |
Why?
| | Electrocardiography | 1 | 2014 | 664 | 0.020 |
Why?
| | Precision Medicine | 1 | 2015 | 454 | 0.020 |
Why?
| | Lung | 1 | 2023 | 4089 | 0.020 |
Why?
| | Brain Mapping | 1 | 2012 | 535 | 0.020 |
Why?
| | Child | 2 | 2020 | 22600 | 0.020 |
Why?
| | Parents | 1 | 2017 | 1395 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5870 | 0.010 |
Why?
| | Injections, Intraventricular | 1 | 1997 | 58 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1997 | 154 | 0.010 |
Why?
| | Organ Size | 1 | 1997 | 461 | 0.010 |
Why?
| | Corticosterone | 1 | 1997 | 242 | 0.010 |
Why?
| | Rats, Wistar | 1 | 1997 | 449 | 0.010 |
Why?
| | Leptin | 1 | 1997 | 247 | 0.010 |
Why?
| | Triglycerides | 1 | 1997 | 517 | 0.010 |
Why?
| | Body Weight | 1 | 1997 | 968 | 0.010 |
Why?
| | Adipose Tissue | 1 | 1997 | 643 | 0.010 |
Why?
| | Diet | 1 | 1997 | 1270 | 0.000 |
Why?
| | Rats | 1 | 1997 | 5570 | 0.000 |
Why?
| | Blood Glucose | 1 | 1997 | 2326 | 0.000 |
Why?
| | Insulin | 1 | 1997 | 2502 | 0.000 |
Why?
| | Animals | 1 | 1997 | 37948 | 0.000 |
Why?
|
|
Arch's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|